VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
3 Initial filing by director officer or owner of more than ten percent
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
4 Statement of changes in beneficial ownership of securities
3,4,5
View HTML
8-K Report of unscheduled material events or corporate event
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
S-8 Securities offered to employees pursuant to employee benefit plans
Registration Statements
XML - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2026 Vanda Pharmaceuticals Inc. |